Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Fc gamma receptor IIB on dendritic cells enforces peripheral tolerance by inhibiting effector T cell responses.

Desai DD, Harbers SO, Flores M, Colonna L, Downie MP, Bergtold A, Jung S, Clynes R.

J Immunol. 2007 May 15;178(10):6217-26.

2.

FcR-bearing myeloid cells are responsible for triggering murine lupus nephritis.

Bergtold A, Gavhane A, D'Agati V, Madaio M, Clynes R.

J Immunol. 2006 Nov 15;177(10):7287-95.

3.

Cell surface recycling of internalized antigen permits dendritic cell priming of B cells.

Bergtold A, Desai DD, Gavhane A, Clynes R.

Immunity. 2005 Nov;23(5):503-14.

4.

Redundant and alternative roles for activating Fc receptors and complement in an antibody-dependent model of autoimmune vitiligo.

Trcka J, Moroi Y, Clynes RA, Goldberg SM, Bergtold A, Perales MA, Ma M, Ferrone CR, Carroll MC, Ravetch JV, Houghton AN.

Immunity. 2002 Jun;16(6):861-8.

5.

Immune complex-mediated antigen presentation induces tumor immunity.

Rafiq K, Bergtold A, Clynes R.

J Clin Invest. 2002 Jul;110(1):71-9.

6.

Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha /beta.

Manca C, Tsenova L, Bergtold A, Freeman S, Tovey M, Musser JM, Barry CE 3rd, Freedman VH, Kaplan G.

Proc Natl Acad Sci U S A. 2001 May 8;98(10):5752-7. Epub 2001 Apr 24.

7.

Immunopathologic effects of tumor necrosis factor alpha in murine mycobacterial infection are dose dependent.

Bekker LG, Moreira AL, Bergtold A, Freeman S, Ryffel B, Kaplan G.

Infect Immun. 2000 Dec;68(12):6954-61.

8.

Aerosol infection of mice with recombinant BCG secreting murine IFN-gamma partially reconstitutes local protective immunity.

Moreira AL, Tsenova L, Murray PJ, Freeman S, Bergtold A, Chiriboga L, Kaplan G.

Microb Pathog. 2000 Sep;29(3):175-85.

PMID:
10968949
9.

Mycobacterium tuberculosis CDC1551 induces a more vigorous host response in vivo and in vitro, but is not more virulent than other clinical isolates.

Manca C, Tsenova L, Barry CE 3rd, Bergtold A, Freeman S, Haslett PA, Musser JM, Freedman VH, Kaplan G.

J Immunol. 1999 Jun 1;162(11):6740-6.

10.

Tumor necrosis factor alpha is a determinant of pathogenesis and disease progression in mycobacterial infection in the central nervous system.

Tsenova L, Bergtold A, Freedman VH, Young RA, Kaplan G.

Proc Natl Acad Sci U S A. 1999 May 11;96(10):5657-62.

Supplemental Content

Loading ...
Support Center